Price T Rowe Associates Inc. MD Boosts Stock Position in Medical Properties Trust, Inc. (NYSE:MPW)

Price T Rowe Associates Inc. MD grew its position in shares of Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 14.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 403,537 shares of the real estate investment trust's stock after purchasing an additional 52,067 shares during the period. Price T Rowe Associates Inc. MD owned approximately 0.07% of Medical Properties Trust worth $1,594,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Dark Forest Capital Management LP purchased a new position in shares of Medical Properties Trust during the fourth quarter valued at approximately $1,130,000. Hsbc Holdings PLC increased its position in shares of Medical Properties Trust by 10.8% during the fourth quarter. Hsbc Holdings PLC now owns 444,240 shares of the real estate investment trust's stock worth $1,755,000 after acquiring an additional 43,172 shares during the period. First Trust Advisors LP boosted its position in Medical Properties Trust by 24.1% during the fourth quarter. First Trust Advisors LP now owns 128,002 shares of the real estate investment trust's stock valued at $506,000 after purchasing an additional 24,839 shares in the last quarter. CANADA LIFE ASSURANCE Co grew its holdings in Medical Properties Trust by 1.4% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 1,385,168 shares of the real estate investment trust's stock worth $5,471,000 after purchasing an additional 18,957 shares during the last quarter. Finally, Demars Financial Group LLC boosted its holdings in Medical Properties Trust by 694.8% in the fourth quarter. Demars Financial Group LLC now owns 215,923 shares of the real estate investment trust's stock valued at $853,000 after purchasing an additional 188,757 shares during the last quarter. 71.79% of the stock is currently owned by hedge funds and other institutional investors.

Medical Properties Trust Trading Down 1.9%

Shares of NYSE:MPW traded down $0.10 during trading on Wednesday, reaching $4.95. 4,353,294 shares of the company traded hands, compared to its average volume of 12,528,697. The business's fifty day moving average is $5.55 and its 200-day moving average is $4.83. Medical Properties Trust, Inc. has a 52-week low of $3.51 and a 52-week high of $6.55. The firm has a market capitalization of $3.00 billion, a price-to-earnings ratio of -1.17, a P/E/G ratio of 1.01 and a beta of 1.41. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt-to-equity ratio of 1.69.

Medical Properties Trust (NYSE:MPW - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The real estate investment trust reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The business had revenue of $223.80 million during the quarter, compared to analyst estimates of $233.80 million. Medical Properties Trust's revenue for the quarter was down 17.5% compared to the same quarter last year. During the same period last year, the firm earned $0.24 EPS. As a group, analysts forecast that Medical Properties Trust, Inc. will post 0.78 EPS for the current year.

Medical Properties Trust Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 10th. Shareholders of record on Monday, March 10th were paid a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a yield of 6.47%. The ex-dividend date of this dividend was Monday, March 10th. Medical Properties Trust's dividend payout ratio (DPR) is currently -11.55%.

Analyst Upgrades and Downgrades

MPW has been the topic of several research analyst reports. StockNews.com upgraded Medical Properties Trust from a "sell" rating to a "hold" rating in a report on Monday, March 3rd. BNP Paribas upgraded shares of Medical Properties Trust from a "neutral" rating to an "outperform" rating and boosted their price objective for the stock from $5.00 to $9.00 in a report on Wednesday, March 12th. Royal Bank of Canada upped their target price on shares of Medical Properties Trust from $4.00 to $5.00 and gave the stock a "sector perform" rating in a research report on Monday, March 10th. Finally, Wells Fargo & Company boosted their price target on shares of Medical Properties Trust from $4.00 to $5.00 and gave the company an "underweight" rating in a report on Monday, March 10th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $5.75.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.